| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.krebsbiochem.com | |
| Market Cap | 154.46 Cr. | |
| Enterprise Value(EV) | 342.28 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -9.66 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.15 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | -52.57 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | -1.36 | Calculated using Price: 71.64 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 2.16 Cr. | 21,560,586 Shares |
| FaceValue | 10 | |
| About Krebs Biochemicals & Industries Ltd. | ||
| Krebs Biochemicals & Industries (KBIL) was established in the year 1991 as a Public Limited Company with the main objective of establishing commercially viable biotech processes with applications in Medicine, Agriculture Industry. The company has pioneered in the fermentation technology over the last decade. | ||
| 1 Day |
|
+3.52% |
| 1 Week |
|
-2.39% |
| 1 Month |
|
+7.07% |
| 3 Month |
|
-10.48% |
| 6 Month |
|
+7.07% |
| 1 Year |
|
-8.24% |
| 2 Year |
|
-58.34% |
| 5 Year |
|
-37.21% |
| 10 Year |
|
+302.13% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 0 | -683.34 | -296.7 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Return on Capital Employed (%) | -4.33 | -25.38 | -27.13 | -28.95 | -35.41 | -56.96 | -40.28 | -57.38 | -28.59 | |
| Return on Assets (%) | -6.44 | -14.6 | -13.46 | -14.38 | -14.92 | -20.91 | -19.36 | -25.51 | -13.54 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 18 | 13 | 1 | -18 | -14 | -25 | -43 | -75 | -99 | -108 | |
| Non Curr. Liab. | 60 | 74 | 89 | 101 | 102 | 116 | 154 | 187 | 225 | 231 | |
| Curr. Liab. | 29 | 30 | 32 | 42 | 55 | 43 | 48 | 78 | 49 | 55 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 107 | 116 | 122 | 126 | 142 | 134 | 159 | 190 | 175 | 178 | |
| Non Curr. Assets | 92 | 107 | 109 | 109 | 111 | 115 | 138 | 154 | 159 | 162 | |
| Curr. Assets | 15 | 9 | 13 | 17 | 31 | 19 | 21 | 35 | 16 | 16 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 107 | 116 | 122 | 126 | 142 | 134 | 159 | 190 | 175 | 178 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 1 | 4 | 34 | 48 | 33 | 54 | 60 | 52 | 50 | ||
| Other Income | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | |
| Total Income | 0 | 2 | 4 | 34 | 48 | 34 | 54 | 61 | 53 | 50 | |
| Total Expenditure | -5 | -14 | -12 | -41 | -58 | -52 | -71 | -94 | -68 | -60 | |
| PBIDT | -5 | -11 | -8 | -7 | -9 | -18 | -17 | -33 | -15 | -10 | |
| Interest | -4 | -1 | -3 | -5 | -6 | -6 | -6 | -5 | -3 | -4 | |
| Depreciation | -2 | -4 | -4 | -4 | -4 | -5 | -5 | -6 | -7 | -7 | |
| Taxation | |||||||||||
| Exceptional Items | 3 | 0 | 0 | -1 | 0 | ||||||
| PAT | -8 | -16 | -16 | -18 | -20 | -29 | -28 | -45 | -25 | -21 | |
| Adjusted EPS | -8 | -12 | -11 | -13 | -12 | -16 | -14 | -21 | -11 | -10 |
| Particulars | 10 years | 2014-09 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 49 | -45 | -15 | -11 | -6 | 4 | -36 | -15 | -17 | -25 | |
| Cash Fr. Inv. | 0 | -3 | -4 | -5 | -3 | -4 | -10 | -23 | -23 | -13 | |
| Cash Fr. Finan. | -49 | 54 | 13 | 16 | 9 | 17 | 29 | 38 | 40 | 37 | |
| Net Change | 0 | 6 | -6 | 0 | 0 | 17 | -17 | 1 | -1 | 0 | |
| Cash & Cash Eqvt | 0 | 6 | 0 | 0 | 0 | 17 | 0 | 1 | 0 | 0 |
|
Mon, 15 Apr 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer Resignation of Mr. Keyur Doshi as Company Secretary and Compliance Officer of the Company. |
|
Mon, 08 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended 31st March 2024. |
|
Mon, 08 Apr 2024
Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulation 2015. |
| Tue, 16 Apr 2024 |
High Delivery Percentage
|
Closing Above Previous High
|
High Increase in 1 Month
|
High Decrease in 2 Years
|
William %R Crossed -20 From Below
|
